Guided Therapeutics Inc
Guided Therapeutics, Inc., a medical technology company, develops medical devices. It focuses on the marketing and sale of LuViva, an advanced cervical scan non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. Th… Read more
Market Cap & Net Worth: Guided Therapeutics Inc (GTHP)
Guided Therapeutics Inc (OTCQB:GTHP) has a market capitalization of $6.66 Million ($6.66 Million) as of March 18, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #34008 globally and #11093 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Guided Therapeutics Inc's stock price $0.08 by its total outstanding shares 80283991 (80.28 Million).
Guided Therapeutics Inc Market Cap History: 2015 to 2025
Guided Therapeutics Inc's market capitalization history from 2015 to 2025. Data shows growth from $1.20 Million to $6.66 Million (4.98% CAGR).
Guided Therapeutics Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Guided Therapeutics Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2179.14x
Guided Therapeutics Inc's market cap is 2179.14 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $2.01 Million | $244.00K | -$10.70 Million | 8.23x | N/A |
| 2018 | $24.09K | $57.00K | $1.02 Million | 0.42x | 0.02x |
| 2019 | $10.68 Million | $36.00K | -$1.92 Million | 296.60x | N/A |
| 2020 | $24.08 Million | $102.00K | -$279.00K | 236.05x | N/A |
| 2021 | $46.56 Million | $81.00K | -$2.07 Million | 574.87x | N/A |
| 2022 | $24.09 Million | $13.00K | -$4.34 Million | 1852.71x | N/A |
| 2023 | $12.36 Million | $98.00K | -$3.49 Million | 126.16x | N/A |
| 2024 | $15.25 Million | $7.00K | -$2.42 Million | 2179.14x | N/A |
Competitor Companies of GTHP by Market Capitalization
Companies near Guided Therapeutics Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Guided Therapeutics Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Guided Therapeutics Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Guided Therapeutics Inc's market cap moved from $1.20 Million to $ 6.66 Million, with a yearly change of 4.98%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $6.66 Million | -56.32% |
| 2024 | $15.25 Million | +23.38% |
| 2023 | $12.36 Million | -48.67% |
| 2022 | $24.09 Million | -48.28% |
| 2021 | $46.56 Million | +93.40% |
| 2020 | $24.08 Million | +125.49% |
| 2019 | $10.68 Million | +44233.33% |
| 2018 | $24.09K | -98.80% |
| 2017 | $2.01 Million | -95.36% |
| 2016 | $43.24 Million | +3490.67% |
| 2015 | $1.20 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Guided Therapeutics Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $6.66 Million USD |
| MoneyControl | $6.66 Million USD |
| MarketWatch | $6.66 Million USD |
| marketcap.company | $6.66 Million USD |
| Reuters | $6.66 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.